These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence of patients receiving renal replacement therapy in El Salvador in 2014. García-Trabanino R; Trujillo Z; Colorado AV; Magaña Mercado S; Henríquez CA; Nefrologia; 2016; 36(6):631-636. PubMed ID: 27267915 [TBL] [Abstract][Full Text] [Related]
5. Cost analysis of integrated renal replacement therapy program in the province of Toledo (2012-2013). Conde Olasagasti JL; Garcia Diaz JE; Carrasco Benitez P; Mareque Ruiz MÁ; Parras Partido MP; Moreno Alia I; Jimenez Lopez L; Cia Lecumberri JJ; Araque P; Fernandez ML Nefrologia; 2017; 37(3):285-292. PubMed ID: 28648205 [TBL] [Abstract][Full Text] [Related]
6. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model. Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A; Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247 [TBL] [Abstract][Full Text] [Related]
7. Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy. Fotheringham J; Fogarty D; Jacques R; El Nahas M; Campbell M Nephron Clin Pract; 2012; 120 Suppl 1():c247-60. PubMed ID: 22964571 [TBL] [Abstract][Full Text] [Related]
8. UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses. Gilg J; Rao A; Fogarty D Nephron Clin Pract; 2013; 125(1-4):1-27. PubMed ID: 24662165 [TBL] [Abstract][Full Text] [Related]
9. UK Renal Registry 16th annual report: chapter 2 UK RRT prevalence in 2012: national and centre-specific analyses. Shaw C; Pitcher D; Pruthi R; Fogarty D Nephron Clin Pract; 2013; 125(1-4):29-53. PubMed ID: 24662166 [TBL] [Abstract][Full Text] [Related]
10. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China. Zhang H; Zhang C; Zhu S; Ye H; Zhang D BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726 [TBL] [Abstract][Full Text] [Related]
11. Consequences of late referral of patients with end-stage renal disease. Gøransson LG; Bergrem H J Intern Med; 2001 Aug; 250(2):154-9. PubMed ID: 11489065 [TBL] [Abstract][Full Text] [Related]
12. Maps of systematic variation in renal replacement therapy in Catalonia (2002-2012). Tebé Condomí C; Arcos E; Comas J; Espallargues M; Pons JMV; Díaz JM; Tort J; Martinez-Castelao A Nefrologia; 2017; 37(2):164-171. PubMed ID: 27884553 [TBL] [Abstract][Full Text] [Related]
13. Burden of disease: Prevalence and incidence of endstage renal disease in Middle Eastern countries. Shaheen FAM; Al-Attar B; Ahmad MK; Follero PM Clin Nephrol; 2020; 93(1):120-123. PubMed ID: 31793874 [TBL] [Abstract][Full Text] [Related]
14. UK Renal Registry 17th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2013: National and Centre-specific Analyses. Gilg J; Pruthi R; Fogarty D Nephron; 2015; 129 Suppl 1():1-29. PubMed ID: 25695805 [TBL] [Abstract][Full Text] [Related]
15. Dedication of a nurse to educating suboptimal haemodialysis starts improved transition to independent modalities of renal replacement therapy. Hanko J; Jastrzebski J; Nieva C; White L; Li G; Zalunardo N Nephrol Dial Transplant; 2011 Jul; 26(7):2302-8. PubMed ID: 21071546 [TBL] [Abstract][Full Text] [Related]
16. Optimizing AVF creation prior to dialysis start: the role of predialysis renal replacement therapy choices. Hanko J; Romann A; Taylor P; Copland M; Beaulieu M Nephrol Dial Transplant; 2012 Nov; 27(11):4205-10. PubMed ID: 22962410 [TBL] [Abstract][Full Text] [Related]
17. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Goovaerts T; Jadoul M; Goffin E Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693 [TBL] [Abstract][Full Text] [Related]
18. UK Renal Registry 13th Annual Report (December 2010): Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses. Steenkamp R; Castledine C; Feest T; Fogarty D Nephron Clin Pract; 2011; 119 Suppl 2():c27-52. PubMed ID: 21894040 [TBL] [Abstract][Full Text] [Related]
19. Social determinants of health influencing the choice of dialysis modality in advanced chronic kidney disease: Need of an interdisciplinary approach. Arenas MD; Fernández-Chamarro M; Pedreira-Robles G; Collado S; Farrera J; Galceran I; Barbosa F; Cao H; Moreno A; Morro L; Fernández-Martin JL; Crespo M; Pascual J Nefrologia (Engl Ed); 2024; 44(4):560-567. PubMed ID: 38997935 [TBL] [Abstract][Full Text] [Related]
20. Mortality in the Veneto population on renal replacement therapy. Nordio M; Tessitore N; Feriani M; Rossi B; Virga G; Amici G; Abaterusso C; Antonucci F; J Nephrol; 2013; 26 Suppl 20():S23-33. PubMed ID: 24293195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]